Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Various Advanced Cancer × Ipilimumab × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 90 Carcinoma, Non-Small-Cell Lung 28 Carcinoma, Renal Cell 19 Prostatic Neoplasms 13 Neoplasm Metastasis 13 Lung Neoplasms 11 Brain Neoplasms 11 Neoplasms 10 Breast Neoplasms 10 Uveal Melanoma 9 Sarcoma 8 Pancreatic Neoplasms 7 Urinary Bladder Neoplasms 6 Small Cell Lung Carcinoma 6 Kidney Neoplasms 6 Carcinoma, Transitional Cell 6 Skin Neoplasms 5 Carcinoma, Hepatocellular 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Diabetes Mellitus, Insulin-Dependent, 12 4 Colorectal Neoplasms 4 Urogenital Neoplasms 3 Triple Negative Breast Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Mesothelioma, Malignant 3 Mesothelioma 3

Interventions

Nivolumab 2 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03130959 2022-08-09

CheckMate 908

Bristol-Myers Squibb

Phase 2 Completed

166 enrolled 33 charts

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡